logo-loader
viewMicro Focus International plc

Micro Focus deal "clearly signals" scope for further deals, says Numis

Micro Focus's deal to acquire software assets from US-listed Progress Software has received the thumbs up from City broker Numis. It also said the company’s performance update was well ahead of expectations, but also noted it was “distorted” by one-offs.

 

business_news_350_50d82b2ebc7ed.jpg

Micro Focus's (LON:MCRO) deal to acquire software assets from US-listed Progress Software has received the thumbs up from City broker Numis.

It also said the company’s performance update was well ahead of expectations, but also noted it was “distorted” by one-offs.

It expects to make a 3% upgrade to revenue and profit forecasts. It has maintained its 'add' recommendation and 631 pence target price.

At 10am, the stock was up 3.5 pence at 573.5 pence, valuing the group at £856mln.

Numis said today’s deal "clearly signals that there is scope for M&A that meets management's aggressive cash flow return targets”.

“The ongoing focus on sustainable cash flows rather than growth should provide further opportunities for Micro Focus to acquire assets as other companies look to shed low/no growth but well established product lines at attractive valuations,” the broker added.


 

Quick facts: Micro Focus International plc

Price: 1098.6 GBX

LSE:MCRO
Market: LSE
Market Cap: £3.66 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks off to rocky start ahead of much-anticipated...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, slipped 1.7% at 130.3 points. Elsewhere, the OTCQX Cannabis Index lost 0.4% at 469.8 points. Buds today were Aleafia Health Inc (TSE:ALEF) (OTCMKTS:ALEAF), CB2 Insights Inc (CSE:CBII)...

17 hours, 31 minutes ago

2 min read